Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines | Eli Lilly and Company Investors | Eli Lilly and CompanyEli Lilly adds $5.3 billion investment in Lebanon LEAP district FOX 59 IndianapolisEli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply CNBCEli Lilly increases LEAP District investment for weight loss drug IndyStarLilly increases investment to Lebanon manufacturing site to $9B WTHR